Skip to content

Interventions for Postoperative Delirium: Biomarker-3

Interventions for Postoperative Delirium: Biomarker-3

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03124303
Acronym
IPOD-B3
Enrollment
468
Registered
2017-04-21
Start date
2017-02-13
Completion date
2029-12-31
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Brief summary

The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.

Interventions

Blood will be collected from participants

DIAGNOSTIC_TESTPupillometry

A pupillometer is a device that measures the size of the pupils.

EEG is a safe non-invasive technology without complications that may be used to help diagnose delirium

PROCEDUREMagnetic Resonance Imaging

MRI scan of brain

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Cohort 1: Age ≥65 years * Cohort 2: Age ≥60 years * Anticipated length of hospital stay of at least 2 days after surgery that occurs under general or neuraxial anesthesia * Written Informed Consent for potential participation prior to surgery

Exclusion criteria

* Contraindication to EEG * Unable or unwilling to attend the follow-up appointments * Documented history of dementia * Deemed incapable of providing consent by surgical team * Residing in a nursing home * Undergoing intracranial surgery * Unable to complete neurocognitive testing due to language, vision or hearing impairment * Unable to communicate with the research staff due to language barriers * For optional MRI portion of the study: Contraindication to MRI (e.g., implanted devices not safe for MRI studies, claustrophobia, unable to lie flat or still)

Design outcomes

Primary

MeasureTime frameDescription
Functional ConnectivityPre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Post-Operative days 1-4Change from baseline functional connectivity at immediate postoperative period and association between delirium (CAM) and functional connectivity of the cingulate cortex
Brain state changePost-operative day 1 through 4Quantified by the MSD across regions of interest from resting state time-series to randomly spaced points across the time-series. Measured for Cohort 2 only.

Secondary

MeasureTime frameDescription
Brain measurementsPreoperative MRI will occur up to 4-weeks prior to surgery. Delirium is followed postoperatively, days 1-4Assess the association between preoperative white matter connectivity (DTI) and cortical thickness (derived from MRI) and postoperative delirium
Long term cognitionPre-operative cognition measures will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Long term post-operative cognition measured 1 year after surgery.Examine the incidence of delirium with change in cognition from preoperatively to one-year postoperatively.
Baseline cognition, specific and global.Cognition is assessed preoperatively. Participants are followed for delirium on postoperative days 1-4Examine the association between preoperative cognition using a neuropsychological battery, and postoperative delirium incidence.
Biomarkers and brain measurementsPre-op measures: up to 4 weeks prior to surgery. Post-op measures: one year, and two years, after surgery.Assess the changes in cognition and biomarkers over one year with EEG changes.
Representativeness of surgical populationPre-op MRI: up to 4 weeks prior to surgery.Identify whether patients who consent to the MRI are reflective of the surgical population.
Genetics and deliriumPre-op blood collected up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative blood collected on postoperative days 1-4. Long term blood collected 90 days and 1 year after surgery.Identify genetic and epigenetic changes associated with delirium and its pathogenesis.
Postoperative amyloid beta deposition and deliriumPost-operative delirium measured on postoperative days 1-4. PET imaging will occur 90 days after surgery.Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography at 90 days after surgery in sub-study IPOD-PET.
Long term changes in amyloid beta deposition and deliriumPre-operative PET imaging will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative PET imaging will occur 1 year after surgery.Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography preoperatively and 1 year after surgery in sub-study IPOD-PET2.
Mismatch negativityPost-operative day 1 through 4EEG mismatch negativity during delirium compared to resolution of delirium.
Resolution of slow wave activityPost-operative day 1 through 4Slow wave activity during delirium compared to resolution of delirium.
InflammationPre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: POD1-4Assess the changes from preoperative to postoperative EEG associated with delirium and change in plasma/cerebrospinal fluid (CSF) IL-6 or other biomarkers (e.g. other cytokines or markers of neronal injury)
Effects of inflammation on brain activityPost-operative day 1 through 4EEG correlations with biomarkers of inflammation and neuronal injury.
Delirium subtypes - neuronal dynamicsPost-operative day 1 through 4EEG neuronal dynamics (energy landscape analysis) during hyperactive vs hypoactive delirium.
Delirium subtypes - predisposing neuronal dynamicsUp to 4 weeks prior to surgery.Preoperative neuronal dynamics between hyperactive and hypoactive delirium.
Delirium subtypes - network stitchingPost-operative day 1 through 4Task evoked network switching and locus coeruleus activity between hyperactive and hypoactive delirium.
Delirium subtypes - network integrationUp to 4 weeks prior to surgery.Preoperative brain network integration vs differentiation between hyperactive and hypoactive delirium.
Pupillary responsesPost-operative day 1 through 4Pupillary response during rest and cognitive task in delirious versus nondelirious participants.
Metabolism and SWAPost-operative day 1 through 4Correlation between SWA location, delirium subtype, and MCT2 expression.
Injury versus inflammation4 weeks prior to surgery to 1 year post-surgeryDelayed resolution of biomarkers of neuronal dysfunction and inflammation as competing theories to neuronal injury.
Neuronal injury - surgery typePost-operative day 1 through 4Association between biomarkers of neuronal injury and type of surgery.
Change in cognitionBaseline to 1 year post-surgeryAssociation of biomarkers of neuronal injury with change in cognition at 1 year.
Connectivity during deliriumPost-operative day 1 through 4Dynamic causal modeling of cortical connectivity during delirium.
BiomarkersPost-operative day 1 through 4Identify biomarkers of delirium and neural damage through changes in circulating plasma proteins and molecules (through mass spectometry)

Countries

United States

Contacts

Primary ContactDavid Kunkel, BS
dkunkel@wisc.edu608-262-6469
Backup ContactFrankie Ingram, BS
fingram@wisc.edu608-262-6469

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026